Products

Corrily

All-in-one platform web & mobile subscription companies use to grow revenue — with paywall design, analytics, AI insights, experiments

corrily.com Finance / Billing & Revenue Analytics

Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
Unknown
Subscription model, plan pricing not identified yet
Creators
Abel Riboulot
No social account linked
Launched
5y ago
2021-02-22 · Est.

Traffic

Monthly visitsData through Oct 2026

Marketing moves

Launches, search & content, referrals, promotions
  • Launched on Product HuntLaunch

    See how inflation affects your SaaS revenue and plan ahead

    Jan 28, 2022 · 4y agoLaunch page

  • Launched on Product HuntLaunch

    Price and discount optimization for subscription services

    Nov 5, 2021 · 5y agoLaunch page

  • Launched on Product HuntLaunch

    Price localization and optimization for SaaS companies

    Feb 22, 2021 · 5y agoLaunch page

Traffic sources

Oct 2026

Traffic breakdown

Channels

No data yet

Countries

No data yet

Search

Domain authority —Domain registered 2020-11-08

No search keyword data for this website yet.

Traffic data: Vaneform

Pricing

Pricing page not identified yet, or no public pricing listed.

Website snapshots

Indexed 2021-02-22

Key pages

Desktop & mobile archive

Website snapshots pending capture.

Questions & evidence

How much website traffic does Corrily get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is Corrily and what platforms does it support?
Corrily is catalogued under Billing & Revenue Analytics: All-in-one platform web & mobile subscription companies use to grow revenue — with paywall design, analytics, AI insights, experiments. Supported platforms: API.

Related products in this category

Finance / Billing & Revenue Analytics

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.